(Q36920386)

English

Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung

scientific article published on 21 February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

0 references

squamous cell carcinoma

1 reference

based on heuristic

inferred from title

Elisabeth Brambilla

9

object named as

Elisabeth Brambilla

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

15

object named as

John K Field

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Ignacio I Wistuba

11

object named as

Ignacio I Wistuba

1 reference

Europe PubMed Central

17 August 2017

PMC publication ID

Jean-François Timsit

13

object named as

Jean-Francois Timsit

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

María J Pajares

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Jackeline Agorreta

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Marta Larrayoz

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Aurélien Vesin

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Teresa Ezponda

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Isabel Zudaire

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Wenceslao Torre

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

María D Lozano

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Christian Brambilla

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Carmen Behrens

12

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Ruben Pio

14

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Luis M Montuenga

16

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

0 references

publication date

21 February 2012

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

30

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1129-1136

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

New driver mutations in non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

The evolving role of histology in the management of advanced non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Targeting the tumour vasculature: insights from physiological angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Pathogenesis of lung cancer signalling pathways: roadmap for therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

VEGF-targeted therapy: mechanisms of anti-tumour activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

VEGF receptor signalling - in control of vascular function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Vascular endothelial growth factor in the lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

29 September 2017

The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

4 September 2018

The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

4 September 2018

Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

4 September 2018

Histology matters: individualizing treatment in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

4 September 2018

Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

4 September 2018

Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

4 September 2018

The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

4 September 2018

Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4874209

4 September 2018

Expression of VEGF and its receptors in different brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of angiopoietins and its clinical significance in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of VEGF, VEGF receptors and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor expression in pN2 non-small cell lung cancer: lack of prognostic value

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of angiogenesis in nonsmall-cell lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting recommendations for tumor marker prognostic studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22355056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2011.37.4231

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36920386&oldid=1924181649"